Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress
Bing‐Dong Sui(Air Force Medical University), Cheng‐Hu Hu(Xi'an Railway Survey and Design Institute)
Cited by 23
Related Papers
Photoreceptor protection by mesenchymal stem cell transplantation identifies exosomal MiR-21 as a therapeutic for retinal degeneration
|Cell Death and Differentiation|2020|152
miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
|Scientific Reports|2017|125
Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery
|Experimental & Molecular Medicine|2018|86
Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis
|Stem Cells Translational Medicine|2016|83